New Regenerative Therapies May Reverse Osteoarthritis; Human Trials Planned by 2028

A groundbreaking and fast-paced effort – combining biologic, clinical and regulatory expertise at the University of Colorado Anschutz – has helped propel an ambitious nationwide attempt to reverse osteoarthritis (OA), a painful degenerative disease that affects 32 million Americans.


Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks